Answers are grounded in this paper and cite their sources.
A retrospective study reveals that objective response indicates survival in metastatic head and neck cancer treated with immune therapy, suggesting its importance in treatment decisions.
This study highlights the prognostic significance of achieving an objective response with first-line ICI-based, not cetuximab-based, treatment in R/M HNSCC.
No takes yet. Share an insight, caveat, or question.
Inoue et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: